To the Editor: In 2008, the regional supply of Ritalin LA (long-acting methylphenidate) to children managed in the government sector was terminated after 2 years of access, returning to the immediate-release formulation. A specialist (FvBD) seeing children at the Red Cross Children’s Hospital and some special schools monitored 57 children with attention deficit hyperactivity disorder (ADHD). By...

METHYLPHENIDATE is a white, water-soluble crystalline compound. It is a piperidine derivative which can be administered orally, subcutaneously, intramuscularly or intravenously and is marketed under the name of "Ritalin" by Ciba Pharmaceuticals. It is a behaviour-alteirmg drug which is often included in the classification of tranquillizer or ataractic compounds (9). In contradistinction to the ...

Seventeen children previously judged to be good or poor responders to methylphenidate (Ritalin) were tested on sensory integrative measures while in the off-drug state. The tester was unaware of the children's drug response category. Results showed that children who were poor responders to Ritalin showed prolonged scores on and an adverse reaction to the Southern California Postrotary Nystagmus...

INTRODUCTION Stimulant medication improves hyperactivity, inattention, and impulsivity in both pediatric and adult populations with Attention Deficit Hyperactivity Disorder (ADHD). However, data regarding the optimal dosage in adults is still limited. CASE PRESENTATION We report the case of a 38-year-old Caucasian patient who was diagnosed with Attention Deficit Hyperactivity Disorder when he...

One hundred children, ages 6-19, who were diagnosed with attention-deficit/hyperactivity disorder (ADHD), either inattentive or combined types, participated in a study examining the effects of Ritalin, EEG biofeedback, and parenting style on the primary symptoms of ADHD. All of the patients participated in a 1-year, multimodal, outpatient program that included Ritalin, parent counseling, and ac...

Methylphenidate hydrochloride (Ritalin) is the drug of choice for attention deficit hyperactivity disorder (ADHD). However, an association of Ritalin with glaucoma has been reported. We report a case of Ritalin-associated cataract and glaucoma. A 10-year-old boy was diagnosed with ADHD and had received methylphenidate hydrochloride, 60 mg/day for 2 years. He presented with blurred vision. Best-...